Cabozantinib most effective treatment for metastatic papillary kidney cancer
26 Feb 2021
Cabozantinib most effective treatment for metastatic papillary kidney cancer
Oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell carcinoma
SEMS trial: result of a prospective, multi-institutional phase II clinical trial of surgery in early metastatic seminoma
TALAPRO-1: phase II study of talazoparib in patients with DNA damage repair alterations and mCRPC
ASCO GU 2021: Renal cancer roundup